Jul 13, 2020 — 3 min read
Lunit, a leading medical AI startup, will be virtually participating at ECR (European Congress of Radiology) 2020, which is scheduled to be held beginning this Wednesday, 15-19 July. This is Lunit’s inaugural participation at the annual meeting, after which the company had received a CE mark for its AI solution for chest and breast radiology, Lunit INSIGHT series. The software detects chest abnormalities from chest x-ray and breast cancer from mammograms, respectively, with an accuracy of 96-99%.
The virtual exhibition will be opened to the registered members beginning the 15th, can be accessed via this link: https://ecr2020.expo-ip.com/ At Lunit’s virtual booth, visitors can watch videos and try online demonstrations to learn more about Lunit INSIGHT products. Lunit sales representatives will also be accepting inquiries through an instant chatting system.
Additionally, medical and AI researchers at Lunit are presenting their studies and findings during ECR academic programs for Breast Radiology and Chest Radiology. The recording of these presentations will be available on-demand on the ECR website. Lunit’s CEO, Brandon Suh will be also presenting about “Precision Diagnostics in Chest and Breast Imaging” during Artificial Intelligence sessions. Below is information about Lunit’s presentations during ECR 2020.
Presentations by Lunit During ECR 2020
Precision Diagnostics in Chest and Breast Imaging
Presenter: Brandon Suh, M.D., M.P.H., M.B.A., CEO of Lunit
RPS 702-1 Breast cancer detection in mammography using artificial intelligence: a large-scale retrospective evaluation
RPS 702-2 Breast cancer detection in screening mammography using artificial intelligence: a multicentre retrospective reader study
RPS 105-1 Deep learning to increase lung cancer detection in chest x-rays: a retrospective cohort analysis of national lung screening trial participants
RPS 1205 -13 On the robustness of a deep learning-based algorithm for detecting abnormalities in chest radiographs across different devices and view positions: a retrospective case-control study
Lunit’s AI solution for radiology, Lunit INSIGHT series provides AI detection and analytics for radiology images. The most mature product within the series, Lunit INSIGHT CXR and Lunit INSIGHT MMG provides AI-powered detection of lesions that are suspicious of chest abnormalities and breast cancer with 96-99% accuracy, by analyzing chest x-ray and mammography images.
The software has been validated through studies published in major peer-reviewed journals such as Radiology, Lancet Digital Health, JAMA Network Open, Clinical Infectious Diseases, and etc. It is also embedded in imaging devices and PACS systems of major vendors such as Fujifilm and GE Healthcare.
Lunit wins Tumor Proliferation Assessment Challenge (TUPAC) 2016
Lunit to unveil data-driven imaging biomarker at RSNA 2016
Lunit to showcase AI-powered products at USCAP 2017
Lunit INSIGHT: The First-ever, Real-time Imaging AI Analytics on the Web
Cognitive biases and augmented intelligence in radiology
Lunit Returns to RSNA with Real-time Imaging Platform, Featuring Cloud-based A
Lunit Unveils “Lunit INSIGHT,” A New Real-time Imaging AI Platform on the Web at RSNA 2017
Lunit INSIGHT: Q&A with Brandon B. Suh, Chief Medical Officer at Lunit
ANNOUNCING: BRANDON SUH, OUR NEW CEO
Lunit preps Korean IPO led by NH Investment Bank
Media Advisory: Lunit at RSNA 2018
Lunit Opens “Lunit INSIGHT for Mammography” for Public Access
Lunit Brings its Newest AI Solution for Mammography to RSNA 2018
Lunit Partners with Fujifilm and Salud Digna to Provide Medical AI Solution in Mexico
Lunit announces new members in its advisory board: Dr. Eliot Siegel, Dr. Linda Moy, and Dr. Khan Siddiqui
Lunit to Introduce Medical AI Solutions at GTC 2019
Lunit to Present Abstracts on AI-powered Precision Pathology at 2019 AACR Annual Meeting
Lunit to Showcase AI Solution for Breast Cancer at SBI 2019
Lunit to Present Findings on the Predictive Power of AI Biomarker for Lung Cancer Immunotherapy at ASCO 2019
Lunit Receives Korea MFDS Approval for its AI Solution for Breast Cancer, Lunit INSIGHT MMG
Lunit Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Lunit Gets Korea MFDS Approval for its AI Solution for Chest X-ray, Lunit INSIGHT CXR 2
Lunit at RSNA 2019
Lunit Announces its First CE Mark for AI-Powered Chest X-ray Analysis Software, Lunit INSIGHT CXR
Lunit AI software clinically installed in global sites—to be presented at RSNA 2019
Lunit Secures $26M in Series C Funding Round, Led by Asian Investors
AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall
Renowned Oncologist Dr. Tony Mok Joins Lunit Advisory Board
Lunit Releases Its AI Online to Support Healthcare Professionals Manage COVID-19
Lunit to Present Findings on the Predictive Power of AI-based Analysis of Immune Phenotype at ASCO 2020
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified
AI Solution for COVID-19, Developed by Medical AI Firm Lunit, Now Has Users in More Than 10 Countries
Lunit Awarded as Technology Pioneer by World Economic Forum
Lunit Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Emergent Connect Partners with Lunit to Provide Cloud Based AI Solutions
AI Analysis Can Improve Lung Cancer Detection on Chest Radiographs
AI has Added Value in Insurance Underwriting Process, Recent Pilot Project Between Lunit and Cathay Financial Innovation Lab Reveals
RSNA 2020--Lunit Collaborates with Global Giants in Presenting its AI Solution at Virtual Booths of GE Healthcare, FujiFilm, and Sectra
AI Proves Its Value in Assistance for Emergency Cases-- With Higher Accuracy and Timely Reporting Time of Chest Radiographs
Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry
AI Can Offer Fast and Reliable Examination to Triage COVID-19 Patients-- A Multicenter Retrospective Study Reveals
Recent Studies Reveal High Performance of Lunit AI in Breast Cancer Detection
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
What do the medical journals say about AI-powered mammography?
Research Using Lunit Demo Website
Lunit Presents AI-powered Pathologic Classification of Immune Phenotype that Predicts Response to Immunotherapy at USCAP 2021
What do the medical journals say about AI-powered chest x-ray interpretation?
Join our webinar with Dr. Fredrik Strand
From retrospective to prospective trials of AI in breast cancer screening
AACR 2021 - Lunit Presents Abstracts Demonstrating the Potential of its AI Biomarker in Cancer Treatment
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?
Case of the Month | Where Is Breast Cancer?
AI-based Analysis of Cancer Tissue Predicts Response to Immunotherapy--Findings to Be Presented at ASCO 2021